SaNOtize Research and Development Corporation
http://www.sanotize.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SaNOtize Research and Development Corporation
Glenmark Chief: Running A Facility In The US Has Been A Struggle
Glenmark readies scale up in the respiratory segment, with Ryaltris set for a US debut and a filing for a generic rival to Flovent anticipated. Running a facility in that market, though, is not an easy task, says the firm's leadership.
Glenmark Chief: Running A Facility In The US Has Been A Struggle
Glenmark readies scale up in the respiratory segment, with Ryaltris set for a US debut and a filing for a generic rival to Flovent anticipated. Running a facility in that market, though, is not an easy task, says the firm's leadership.
SaNOtize, Lupin In Legal Row Concerning COVID-19 Nasal Spray
Canada-based biotech firm SaNOtize and Lupin battle it out in court over alleged breach of confidentiality and copyright infringement in a case concerning their nitric oxide nasal spray for COVID-19.
Watch This Space: Glenmark-SaNOtize’s COVID-19 Nasal Spray Debuts In India
Glenmark's partnered nitric oxide nasal spray for COVID-19 debuts in India at about $11, with the firm spotlighting the reduction in viral load with the product and potential to cut the chain of transmission. But more competition appears to be in the wings.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery